Navigation Links
Drug Trial Victims Could Develop Cancer

The victims of a drugs trial which went wrong could now develop serious illnesses like cancer according to the solicitor representing them.//

The six volunteers of the trials at Northwick Park Hospital in north-west London were left seriously ill earlier this year.

Martyn Day, a solicitor for several of these men said that they were left to face "the most terrible future".

Parexel, a clinical research organization, which arranged the trials, on behalf of TeGenero, a German pharmaceutical company claims that all guidelines were followed.

One of the victims, Nav Modi, found out that his immune system was unlikely to be able to fight off serious illnesses, from independent tests carried out on him and three other victims, arranged by Mr Day.

He said, "I don't know what's going to happen the next day. Every time I go to bed I feel that I won't be able to see the sun tomorrow."

Following the drug TGN1412 trial Mr Modi suffered multiple organ failure and is now seeking compensation.

Mr Day, said: "The reality is that they're going to have to face the most terrible future prospect of the most serious cancers happening at any time, the prospect of serious diseases, the most terrible, terrible time."

The Medicines and Healthcare products Regulatory Authority (MHRA) had previously stated that Parexel failed to follow proper procedures. In addition it was found that there was no contract in place between TeGenero and Parexel at the beginning of the trial.

TeGenero has continuously claimed that the men's reactions were "completely unexpected" and did not reflect the results obtained from the earlier laboratory studies.


Page: 1

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Vaccine For Dengue Fever On Trial In Asia-Pacific
3. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
4. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
5. Sex, Race Influence Lung Cancer Trial Participation
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
8. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
9. China Begins Human Trials For HIV/AIDS Drug
10. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
11. HIV/AIDS Vaccine Trial To Be Initiated Soon
Post Your Comments:

(Date:11/24/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... planning and monitoring. Their Care Plan software creates an agreement between the ... patient care plan, including financial, scheduling, monitoring, notification, and projections. Click ...
(Date:11/24/2015)... ... 24, 2015 , ... Eric C. Seidel, DMD and Stephanie ... the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses light ... dentist in Gettysburg, PA . From routine visits to cosmetic treatments, laser ...
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA ... Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. ... traditional cutting tools, such as the scalpel and high-speed drill, which can both cause ...
(Date:11/24/2015)... Mississauga, ON (PRWEB) , ... November 24, 2015 , ... ... Deborah Williams without a referral for dental implants at her Mississauga, ON ... qualified and experienced in the placement of dental implants. , Missing teeth can ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a wide variety ... Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in Tucson, AZ ... the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the patient during ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
(Date:11/25/2015)... November 25, 2015 --> ... sie eine Lizenz für das Patent über eine neue ... und ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... ins Leben gerufenen und von Edelris gemeinsam mit seinen ... ein Behandlungsziel für HBV identifiziert, und es wurden neue ...
(Date:11/25/2015)... November 25, 2015 ... addition of the  "Global Drug Device ... to their offering.  --> ... of the  "Global Drug Device Combination ... their offering.  --> Research ...
Breaking Medicine Technology: